Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1358296,Ael3,Aortic elastin QTL 3,3.7,0.00051,aorta elastin amount (VT:0003905),aortic elastin,14,10539977,55539977,Rat,n/a,region,qtl 1000,634352,Apr6,Acute phase response QTL 6,3.7,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),14,1,42766285,Rat,n/a,region,qtl 1000,2300183,Bmd60,Bone mineral density QTL 60,5.7,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),14,1,27597761,Rat,n/a,region,qtl 1000,2300159,Bmd61,Bone mineral density QTL 61,5.3,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),14,1,27597761,Rat,n/a,region,qtl 1000,7411573,Bw139,Body weight QTL 139,4.7,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),14,1,41333960,Rat,n/a,region,qtl 1000,1331740,Bw26,Body weight QTL 26,3.028,,body mass (VT:0001259),body weight (CMO:0000012),14,4833233,33040042,Rat,n/a,region,qtl 1000,9589814,Gluco67,Glucose level QTL 67,4.54,0.001,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),14,1,41333960,Rat,n/a,region,qtl 1000,2293089,Iddm31,Insulin dependent diabetes mellitus QTL 31,4.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),14,4833233,19909932,Rat,n/a,region,qtl 1000,2293089,Iddm31,Insulin dependent diabetes mellitus QTL 31,4.7,,blood glucose amount (VT:0000188),age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140),14,4833233,19909932,Rat,n/a,region,qtl 1000,70195,Mcs8,Mammary carcinoma susceptibility QTL 8,4.28,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),14,4833233,26466248,Rat,n/a,region,qtl 1000,71115,Niddm15,Non-insulin dependent diabetes mellitus QTL 15,4.8,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),14,2227825,12680613,Rat,n/a,region,qtl 1000,70204,Niddm20,Non-insulin dependent diabetes mellitus QTL 20,5.1,0.000008,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),14,2227825,19230541,Rat,n/a,region,qtl 1000,731183,Pia20,Pristane induced arthritis QTL 20,3.55,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),14,10729268,61873323,Rat,n/a,region,qtl 1000,2302045,Pia39,Pristane induced arthritis QTL 39,4.9,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G2a level (CMO:0002116),14,10539977,55539977,Rat,n/a,region,qtl 1000,1581500,Renag1,Renal agenesis QTL 1,,,kidney development trait (VT:0000527),percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940),14,9756435,72854397,Rat,n/a,region,qtl 1000,619619,Rf4,Renal disease susceptibility QTL 4,4.1,0.002,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),14,1,34403399,Rat,n/a,region,qtl 1000,1300114,Srn2,Serum renin concentration QTL 2,3.27,,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),14,4833233,23004027,Rat,n/a,region,qtl